|
BOSTON, Mass. (February 5, 2007) — T3 Advisors, a full-service real estate brokerage and consulting firm for corporations focused on the innovation economy, today announced it has secured an additional 4,300 square feet for Abcam, an online distributor of antibodies. With the added space, the UK-based company significantly expands its US headquarters at One Kendall Square in Cambridge as demand for its antibody products grows.
Mark Cote, principal of T3 Advisors, represented Abcam. Bob Doherty represented the landlord, The Beal Companies.
“T3 Advisors was instrumental in securing the additional space needed for our US headquarters. As the demand for our antibodies grows, our operations are expanding rapidly as well. We greatly needed more space from which to meet our customers’ expectations,” said Neil Hayward, director and general manager of Abcam, Inc. “T3 skillfully negotiated our additional lease, then went the extra mile to assist with renovating the two office spaces into one.”
About Abcam. Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts, and a recently-established office in Tokyo, Japan. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the company’s website, www.Abcam.com. The company’s vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalog of over 29,000 products, most of which are antibodies, each supported by up-to-date and detailed technical data sheets. The company currently employs over 130 staff.
|
